Originally published In Press as doi:10.1074/jbc.M106711200 on November 7, 2001
J. Biol. Chem., Vol. 277, Issue 4, 3020-3029, January 25, 2002
DNA-dependent Protein Kinase Catalytic Subunit
STRUCTURAL REQUIREMENTS FOR KINASE ACTIVATION BY DNA ENDS*
Susanne
Mårtensson
and
Ola
Hammarsten
§
From the
Department of Clinical Chemistry,
Sahlgrenska University Hospital, Gothenburg University, SE-413 45 Gothenburg, Sweden
Received for publication, July 17, 2001, and in revised form, October 16, 2001
 |
ABSTRACT |
DNA-dependent protein kinase (DNA-PK)
is a DNA end-activated protein kinase composed of a catalytic subunit,
DNA-PKcs, and a DNA binding subunit, Ku, that is involved in repair of
DNA double-stranded breaks (DSBs). We have previously shown that
DNA-PKcs interacts with single-stranded DNA (ssDNA) ends with a
separate ssDNA binding site to be activated for its kinase activity.
Here, the properties of the ssDNA binding site were examined by using
DNA fragments with modified ssDNA extensions. DNA fragments with a wide
range of ssDNA modifictations activated DNA-PKcs, indicating a relaxed specificity for the chemical structure of terminal nucleotides of a
DSB. Methyl substitution of the phosphate backbone impaired kinase
activation but not binding, indicating that interaction with the DNA
backbone was involved in kinase activation. Experiments with RNA and
RNA/DNA hybrid fragments suggested that the discrimination between RNA
and DNA ends resides in the double-stranded DNA binding function of
DNA-PKcs. DNA fragments exposing only one ssDNA end activated DNA-PKcs
poorly, suggesting that DNA-PKcs distinguishes between DSBs and ssDNA
breaks by simultaneous interaction with two ssDNA ends. These
properties potentially explain how DNA-PKcs can be specifically
activated by DSBs but still recognize the diverse chemical structures
exposed when DSBs are introduced by ionizing radiation.
 |
INTRODUCTION |
The resolution and detection of DNA double-stranded breaks
(DSBs)1 is important in
maintaining genomic integrity. A single DSB can lead to chromosomal
fragmentation and cell death or to chromosomal translocations and
cancer. DSBs are induced by ionizing radiation, DNA replication or
V(D)J recombination, a site-specific recombination process that
generates the molecular diversity of the immune system. In response to
ionizing radiation, cells target DSBs for repair and also activate
several signaling pathways that lead to cell cycle arrest or apoptosis
(1). Several protein kinases involved in the DSB signaling pathway have
been identified and include DNA-dependent protein kinase
(DNA-PK), ATM (2), and ATR, members of the phosphatidylinositol
3-kinase superfamily (3) (4-6). Since a single DSB is sufficient to
permanently halt the cell cycle in yeast cells (7-9) and likely in
mammalian cells (10), the signal that is generated must be massively
amplified and tightly regulated.
DNA-PK may be the first protein to bind to a newly generated DSB, as
suggested by its specificity for binding to and activation by DSBs, its
cellular abundance, and the fact that it constitutes the major
end-binding activity in nuclear extracts from human cells (11-14).
Other lines of evidence also indicate that DNA-PK is involved in the
cellular response to DSBs. DNA-PK kinase activity is required for
effective DSB repair, survival (15-18), and recovery of DNA
replication following ionizing radiation (19). DNA-PK has also been
reported to be required for induction of apoptosis in response to
ionizing radiation in thymocytes (20). Thus, DNA-PK appears to signal
the presence of DSBs by its kinase activity. DNA-PK activation by DSBs
can therefore be used as a model for how proteins specifically
recognize and signal the presence of DSB lesions.
DNA-PK is a serine-threonine protein kinase that is composed of a
465-kDa catalytic subunit, DNA-PKcs, (21) and a DNA-binding component,
termed Ku (12). Ku is a heterodimer of 70 and 86 kDa that binds
specifically to DSBs (22-25) as a preformed ring that encircles DNA
(26). DNA-PKcs contains a separate DNA binding function that binds DNA
ends with lower affinity and specificity compared with Ku (27-29).
DNA-PKcs and Ku show only weak association in the absence of DNA (30).
However, when Ku binds to a DNA end, a 12-amino acid sequence from the
Ku80 C terminus becomes exposed that specifically binds and recruits
DNA-PKcs to the DNA end (31, 32). In addition, Ku translocates inwardly
from the DNA end, permitting DNA-PKcs to interact with the terminal
nucleotides (25, 28). The cooperative interactions between DNA-PKcs,
the DNA end, and the C terminus of Ku80 result in stable assembly of
DNA-PK and robust kinase activation. This model for DNA-PK assembly is
supported by specific photocross-linking of DNA-PKcs, but not Ku, to
the terminal nucleotides when DNA-PKcs and Ku assemble on DNA ends
(33).
In its purified form, DNA-PK kinase activity is specifically activated
by double-stranded DNA ends (12). We have further specified that DNA-PK
activation involves interaction with ssDNA ends exposed at the DSB
(34). In addition, we have provided support for the existence of
separate single- and double-stranded DNA binding sites in DNA-PKcs
(35). Despite these advances, we still have limited knowledge of how
chemical modifications of the terminal nucleotides of a DSB affect
kinase activation. This is relevant, since a majority of DSBs generated
by ionizing radiation expose nucleotides with altered chemistry, such
as thymidine glycol, 8-hydroxyguanine, and phosphoglycolate that
preclude direct repair. (36). Because DNA-PK is required for efficient
repair of ionizing radiation-induced DSBs, the enzyme must be able to recognize these altered chemical structures. Indeed, it has been shown
that DNA-PK is activated by DSBs introduced by ionizing radiation and
DNA fragments that end with 3'-phosphoglycolates (37). It is possible,
however, that a subset of the DSBs produced by ionizing radiation are
not recognized by DNA-PK and thus are inefficiently repaired, such as
DNA ends damaged with cis-platin (38-40).
Several studies have shown that ssDNA breaks (SSBs) activate DNA-PK
poorly (11, 37, 41). Based on a low resolution structure of DNA-PKcs,
we have proposed that kinase activation results when a ssDNA end is
inserted into an enclosed channel present in the enzyme (35). This
model provides a possible explanation for the requirement of ssDNA ends
for kinase activation, since double-stranded DNA would not be able to
enter the enclosed channel. However, a SSB potentially exposes ssDNA
ends by fraying. Therefore, the requirement of ssDNA ends does not
provide an explanation for how DNA-PK discriminates between SSBs and DSBs.
Because of the potential general importance of DNA-PK activation by
DSBs in DNA damage signaling, we have analyzed the requirements for
DNA-PKcs kinase activation by DSBs. A series of symmetrical DNA
fragments with defined modifications of the terminal nucleotides were
synthesized. The DNA fragments were tested for their ability to bind
and activate DNA-PKcs. We found that a wide range of modified nucleotides activated DNA-PKcs, indicating a relaxed specificity for
the chemical nature of the DNA terminus. In addition, DNA-PKcs kinase
activation seemed to require interaction with two single-stranded ends,
which potentially explains why DSBs, but not SSBs, are capable of
activating DNA-PK effectively. The data suggest how DNA-PK can be
specifically activated by DSBs but still permissive for the diverse
chemical structures exposed when DSBs are introduced by ionizing radiation.
 |
MATERIALS AND METHODS |
DNA-PKcs Purification--
Placenta extract was prepared as
described previously (28) with modifications. After the 65%
ammonium sulfate precipitation the pellet was dissolved in 100 ml of
buffer E (50 mM Tris-HCl, pH 7.5, 5 mM EDTA,
0.35 M NaCl, 5% glycerol, 0.02% sodium azide, 20 mM 2-mercaptoethanol, and protease inhibitors (28)) and the conductance adjusted by additions of solid NaCl corresponding to 2 M NaCl. Proteins that coprecipitate DNA-PKcs during
dialysis were removed by polyethylene glycol 8000 precipitation (5%,
final concentration) for 30 min followed by centrifugation for 30 min at 10,000 rpm. The supernatant was dialyzed with 10 volumes of buffer E
for 10 h and diluted with dilution buffer (10 mM
Tris-HCl, pH 7.4, 1 mM EDTA, 10% glycerol, 20 mM 2-mercaptoethanol, and protease inhibitors (28)) to a
conductance corresponding to 0.1 M NaCl. The diluted
extract was passed through a 5-ml oligonucleotide affinity column
prepared as described previously (28). Bound proteins were
step-eluted with buffer B supplemented with 1 M NaCl and
precipitated with 65% ammonium sulfate. Precipitated proteins were
dissolved in 700 µl of buffer E supplemented with glycerol to a final
concentration of 25% and separated on a 75-ml Sephacryl S300HR
(Amersham Biosciences, Inc.) gel filtration column equilibrated
in the same buffer. Fractions were analyzed on 5% SDS-PAGE. Fractions
containing DNA-PKcs was pooled, diluted with dilution buffer to a
conductance corresponding to 0.1 M NaCl, and fractionated
on a second oligonucleotide affinity column (1-ml resin volume) as
described previously (28). The pooled fractions from the
oligonucleotide affinity resin were diluted with dilution buffer to a
conductance corresponding to 0.1 NaCl and DNA-PKcs bound to a 0.5-ml
High Q column (Bio-Rad) equilibrated in buffer E with a final
concentration of 0.05 M NaCl. DNA-PKcs was step eluted with
buffer E and stored at
70 °C. For kinase experiments frozen
aliquots of DNA-PK (0.5 mg/ml) were diluted 20-40-fold in storage
buffer (34), stored at
20 °C, and used within 2 weeks.
Kinase Assay and Electromobility Shift Assay (EMSA)--
Kinase
assays were performed as described previously (34). In these
experiments, DNA was added prior to DNA-PKcs, since it was found that
other orders of addition had a negative effect on the reproducibility
of the assay. The final NaCl concentration in kinase reactions was 15 mM after addition of DNA-PKcs. The activity obtained in the
absence of added DNA was defined as background and subtracted from each
value obtained in the presence of DNA. The background-subtracted values
were plotted as a function of DNA concentration and fitted to
Michaelis-Menten equation with KaleidiaGraph software. EMSA sample mix
was prepared by mixing of labeled f12-3T (see "Construction and
Purification of Oligonucleotides") in EMSA buffer (10 mM Tris-HCl, 1 mM EDTA, 5% glycerol, 20 mM 2-mercaptoethanol, and 0.2 mg/ml bovine serum albumin)
to a final concentration of 1.5 nM. EMSA sample mix (8 µl) was mixed with competitor DNA diluted in TE buffer before
addition of 0.6 µl of DNA-PKcs (0.02 mg/ml in storage buffer). After
incubation for 10 min at room temperature, samples were analyzed by
EMSA as described previously (28).
Construction and Purification of
Oligonucleotides--
Oligonucleotides were synthesized on ABI
oligonucleotide synthesizers using standard coupling and deprotection
protocols. Phosphoamidites were purchased from Glen Research. The
sequence of the f12 series of oligonucleotides was identical to the f12 DNA fragment (upper strand, f12-1: 5'-GGCCGCACGCGT-3'; lower strand, f12-2: 5'-ACGCGTGCGGCC-3') except for the single-stranded extensions indicated for each DNA fragment in figures. Both the 5' and the 3'
termini contained hydroxyl groups to facilitate comparison between
different DNA fragments. Annealing the upper strand of f12-3T with the
lower strand of f12-3A formed the 18-bp, blunt-ended DNA fragment, f18.
Oligonucleotides with exclusively 3' or 5' termini were synthesized
using the 5'-5' or 3'-3' linkage phosphoamidites, respectively, from
Glen Research. Single-stranded oligonucleotides were annealed in
1:1 molar ratio and the double-stranded product purified on 15% PAGE.
The gels were stained with ethidium bromide and DNA visualized under
long wave length UV light. The band corresponding to the full-length
product was cut out. DNA was extracted by crushing the gel fragment and
incubating in 10 volumes of extraction buffer (10 mM
Tris-HCl, pH 7.5, 1 mM EDTA, 1 M NaCl) with
vigorous shaking overnight at room temperature. Gel pieces were removed
by centrifugation and the DNA bound to a 50-mg Sep-Pac C18 column
(Waters) prewashed sequentially with acetonitrile, 30% acetonitrile,
100 mM TEAA (triethylammonium acetate), pH 7.0 (Sigma), and
25 mM TEAA, pH 7.0. Bound DNA was washed with 25 mM TEAA, pH 7.0, and eluted with 0.6 ml of 30%
acetonitrile and 100 mM TEAA, pH 7.0. The collected eluate
was then extracted with phenol/chloroform to remove ethidium bromide
and precipitated with ethanol. DNA pellets were washed two times with
99% ethanol, dissolved in TE buffer (10 mM Tris-HCl, pH
7.5, 1 mM EDTA) and dialyzed extensively with TE buffer.
A dumbbell DNA fragment ending with ssDNA loops and containing a
10-base gap in the middle of the fragment (D34-gap10) was formed by
annealing-mediated folding over of a self-complementary oligonucleotide
(5'-TTTGGCCGCACGCGTTTACGCGTGCGGCCTTTTTTTTTTTGACAGGCTCCGCTTGCGGAGCCTGTCTTT-3') followed by purification on 15% PAGE. Three bases of unpaired dT
were added to the 3' and 5' end to facilitate exposure of the ssDNA
ends flanking the gap (Fig. 9). Similarly, a hairpin DNA fragment
(H12-ss3'/5') with a ssDNA loop at one end and unpaired ssDNA ends at
the other end was formed by annealing-mediated folding over of a
self-complementary oligonucleotide
(5'-TTTGGCCGCACGCGTTTTACGCGTGCGGCCTTTTTTTTTT-3'). The
sequence of H12-ss3'/5' is identical to one-half of the D34-gap10 oligonucleotide, including the gapped section. The structure of these
DNA fragments are shown in Fig. 9.
The D45-ss5' DNA fragment was constructed as depicted in Fig.
8B. A phosphorylated oligonucleotide containing a
symmetrical branch (CLONTECH) (f12-2branch:
5'-PCTCCTT-branch-GGAGACGCGTGCGGCG-3") was synthesized. The sequence of
the branch was complementary to the sequence immediately 3' to it, such
that one of the two arms of the branch looped back to form a hairpin
structure while the other remained a single-stranded tail (Fig.
8B). Oligonucleotide f12-2branch was annealed with and
ligated to a phosphorylated complementary oligonucleotide (Br.5:
5'-pTTCTCACGCCGCACGCGT-3'). The ligation product was purified on a 15%
denaturing PAGE and subsequently ligated to a second hairpin structure
(f55-NRE2, 5'-TGAGAAAGAGAAAGACGACATCCGCCTGTTTTTCAGGCGGATGTCGTCTTTCTCT-3') as shown in Fig. 8B. This ligation product was
purified on a native 15% PAGE followed by separation on a 15%
denaturing PAGE run at 75 °C. Under these conditions, the fully
ligated product migrated more slowly than the partially ligated
oligonucleotide as described previously (34). The fully ligated
product was excised from the gel, extracted, and purified as described
above and characterized by labeling with TdT or PNK described below
(Fig. 8C).
The lariat-forming oligonucleotide, lariat, was constructed by fusing
the 3' ends of two partially complementary oligonucleotides (L2 and L3)
as depicted in Fig. 8C. First L2 (L2:
5'-TTTTGGACGCGTGCGGCCTTTTTGGTGTT-3', sequence complementary
to L3 is underlined) was annealed to L1 (L1: 5'-AAGGAAACACCAAAAA-3') to
form a partially double-stranded DNA fragment with a five-nucleotide
5'-extension. The five-nucleotide extension was complementary to a
branched oligonucleotide synthesized using the branching phosphamidite
from CLONTECH (Branch.1: 5'-TCCTT-branch-T-3', Fig.
8C). The structure of Branch.1 is depicted in Fig.
8C. The ligation product
(TTTTGGACGCGTGCGGCCTTTTTGGTGTTTCCTT-branch-T-3') was
purified on 20% denaturing PAGE, eluted as described above, and
ligated to oligonucleotide L3 (L3:
5'-TTTGGCCGCACGCGTCCATTTTTGGTGTT-3', sequence complementary
to L2 is underlined). Prior to ligation, L3 was annealed to L1 to form
a five-nucleotide 5'-extension complementary to the branched
oligonucleotide and to oligonucleotide f12-2 to block annealing between
the 15 bases of complementary sequence in L2 and L3 during the ligation
reaction. The ligation product was purified on 20% denaturing PAGE,
which separated it from L1 and f12-2, and allowed to self-anneal in TE
buffer. The lariat DNA fragment was analyzed by labeling with PNK and
TdT (below) to show that it lacked 3' ends, analysis on native PAGE to
show the abnormally slow migration expected for such a single-stranded loop, and cleavage with the restriction enzyme BstUI
to show that the complementary sequences in the lariat DNA fragment
annealed properly (Fig. 8D). The DNA fragments D32-ssL5,
f42, and f32-ss3'/5' have been described previously (34).
Labeling and Enzyme Digestion of
Oligonucleotides--
Oligonucleotides were labeled on the 5' end
by incubating with 2U T4 polynucleotide kinase (Promega) and
[
-32P]ATP (5000 µCi/mmol, Amersham Biosciences,
Inc.) in 10 µl of kinase buffer (Promega) for 30 min. The 3'
end of oligonucleotides was specifically labeled with 5U terminal
nucleotidyltransferase in 10 µl of TdT buffer (Promega) with
[
-32P]dCTP (5000 µCi/mmol, Amersham Biosciences,
Inc.) at 37 °C for 30 min. Labeled oligonucleotides were separated
from unincorporated nucleotides by spin column chromatography on
Sephadex G25 resin (Amersham Biosciences, Inc.). The upper
strand of f12RNA-3U (f12RNA-3U-1: 5'-UUUGGCCGCACGCGUUUU-3') and f12-3T
(f12-3T-1) was labeled as described above and digested with 0.01 mg/ml
RNase A (Sigma) or 0.05 unit of RNase-free DNase I (Promega) in 10 µl
of TE buffer supplemented with 20 mM MgCl2 for
30 min at room temperature. Reactions were stopped by addition of 3 µl of formamide before analysis on 15% denaturing PAGE.
 |
RESULTS |
Experimental Setup--
We and others (27-29) have shown that the
catalytic subunit of DNA-PK, DNA-PKcs, binds to and is activated for
its kinase activity by double-stranded DNA ends in the absence of Ku.
Under low salt conditions and using short DNA fragments with unpaired
ssDNA at the ends, the kinase activity of DNA-PKcs is actually higher
when Ku is omitted from the reaction (28, 34). In addition, several lines of evidence suggest that DNA-PKcs interacts directly with ssDNA
ends when DNA-PKcs assembles on DNA fragments alone and when it binds
DNA in a complex with Ku (33-35). We have therefore continued to
characterize DNA-PKcs interaction with ssDNA in the absence of Ku,
since the exclusion of Ku makes the experimental system more amenable
to analysis by simple Michaelis-Menten kinetics and determinations of
binding constants.
To explore DNA-PKcs interaction with ssDNA ends, a series of DNA
fragments with modified nucleotides were synthesized. The design of
these DNA fragments was based on the observation that a 12-bp
blunt-ended DNA fragment, f12, is too short to allow efficient DNA-PKcs
activation and binding (Fig. 1) (35). In
contrast, f12-3T, which differs from f12 by addition of three bases of
unpaired dT at each end, activated DNA-PKcs 20-fold more efficiently
and bound DNA-PKcs with over a hundredfold higher affinity compared with the f12 DNA fragment (Fig. 1). Thus, both binding and activation of DNA-PKcs by f12-3T was dependent on the three bases of unpaired ssDNA.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
The base in ssDNA is not required for binding
and activation of DNA-PKcs. A, DNA-PKcs (2 nM) was incubated with different concentrations of the DNA
fragments defined in B, and the resulting kinase activity
was measured. The kinase activity was related to the maximal kinase
activity obtained with the DNA fragment f12-3T (100 = 345 mol of
PO4/mol of DNA-PKcs/min). The data were fitted to the
Michaelis-Menten equation to obtain Km and
Vmax values for activation by each DNA fragment
that is listed in Table I. B, the DNA fragments used in this
experiment include a 12-bp (f12) and an 18-bp (f18) blunt-ended DNA
fragment. Annealing the upper strand of f12-3T with the lower strand of
f12-3A formed the f18 DNA fragment. Fragments with unpaired
single-stranded extensions include f12-3T, f12-3A, and f12-3AP with 3 bases of unpaired dT, dA, or abasic deoxynucleotides at the 3' and
5'ends, respectively. For each DNA fragment, the overall structure of
the DNA fragment and the chemical structure of the three unpaired
nucleotides of the 5' terminus are shown.
|
|
In this study, the difference in activation between f12 and f12-3T was
used to explore which part of ssDNA is responsible for DNA-PKcs
activation and DNA binding. For this purpose, symmetrical DNA fragments
derived from f12-3T were constructed where the three bases of unpaired
dT were replaced with normal or modified nucleotides. The DNA fragments
were then tested for their ability to bind and activate DNA-PKcs. We
postulated that if DNA-PKcs failed to interact with the modified bases,
neither kinase activation nor DNA binding would improve compared with
the f12 DNA fragment. In contrast, if DNA-PKcs was able to interact
with the extension of modified bases, efficient binding and kinase
activation would be observed.
DNA-PKcs kinase reactions were performed over a wide range of DNA
concentrations. The data from kinase reactions were analyzed by best
fit to the Michaelis-Menten equation to allow determination of
Vmax and apparent Km (Table
I). Because components of the reaction
other than DNA were present in saturating amounts, the assumption was
made that DNA binding was the rate-limiting step for kinase activation.
Therefore, the apparent Km was used to reflect the
binding of DNA-PKcs to each DNA fragment.
View this table:
[in this window]
[in a new window]
|
Table I
Kinetics of DNA-PKCS activation for different DNA fragments
Data from Figures 1-4 and 6 was used to calculate
Km and Vmax by best fit to the
Michaelis-Menten equation, V = (Vmax
[S])/(Km + [S]), where
[S] is the DNA concentration. The R value is a
measure of the quality of the fit, with R = 1 representing a perfect fit. The Km for
f12-3T/CH3 was not determinable (ND), because kinase
activation was too weak to permit reliable measurements.
|
|
Effect of Base Alterations on DNA-PKcs Kinase Activation by
DNA--
To study DNA-PKcs interaction with the base in ssDNA, DNA
fragments with unpaired dA, dT, or abasic nucleotides at each end were
used to activate DNA-PKcs (Fig. 1). As reported previously, a
blunt-ended DNA fragment with the same number of nucleotides as f12-3T
(f18) activated DNA-PKcs to a level 2-fold lower than f12-3T and bound
the enzyme with 3-fold lower affinity (Fig. 1, Table I). As expected,
addition of three bases of dA also stimulated kinase activation and
binding but to a lesser extent compared with f12-3T. To test whether
DNA-PKcs interaction with the base in the single-stranded extension was
important for kinase activation, abasic nucleotides were used to
synthesize f12-3AP (Fig. 1). The resulting DNA fragment, with abasic
single-stranded extensions, bound and activated DNA-PKcs to the same
level as observed with f12-3A. Therefore, DNA-PKcs favors DNA fragments
ending with unpaired dT, but the base in ssDNA was not required for
efficient kinase activation or binding.
Effect of Strand Polarity on DNA-PKcs Kinase Activation by
DNA--
To examine the strand polarity preference for DNA-PKcs
interaction with ssDNA, DNA fragments with exclusively 3' (f12-3T/3') or 5' (f12-3T/5') termini were synthesized by introduction of 3'-3' or
5'-5' linkages, as shown in Fig.
2B. The sequence and overall
structure were otherwise identical to the f12-3T DNA fragment.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
DNA fragments with exclusively 3' or 5'
termini activate DNA-PKcs. A, DNA-PKcs (2 nM) was incubated with different concentrations of the DNA
fragments defined in B and the resulting kinase activity
measured. The kinase activity was related to the maximal kinase
activity obtained with the DNA fragment f12-3T (100 = 345 mol of
PO4/mol of DNA-PKcs/min). The data were fitted to the
Michaelis-Menten equation to obtain Km and
Vmax values for each DNA fragment that is listed
in Table I. B, DNA fragments used in this experiment.
Oligonucleotides with exclusively 5' or 3' termini were made by
introduction of 3'-3' or 5'-5' linkages as described under "Materials
and Methods." C, analysis of DNA fragments by labeling
with different enzymes. The unmodified DNA fragment f12-3T and DNA
fragments with exclusively 3' (f12-3T/3') or 5' (f12-3T/5') termini
were labeled with T4 polynucleotide kinase (PNK, specific for 5' ends)
or TdT (specific for 3' ends) as described under "Materials and
Methods." Labeled DNA was separated on a 15% denaturing PAGE and
analyzed by autoradiography.
|
|
To show that the fragments exposed the expected strand polarity the
fragments were labeled with T4 PNK or TdT that specifically labels the
5' or the 3' termini of DNA, respectively. As shown in Fig.
2C, PNK failed to label f12-3T/3' and TdT failed to label f12-3T/5'. This demonstrated that f12-3T/3' exposed exclusively 3'
termini, and f12-3T/5' exposed only 5' termini.
The fragment with only 3' ends (f12-3T/3') bound and activated DNA-PKcs
as well as f12-3T (Table I). The DNA fragment with only 5' termini
activated DNA-PKcs to even higher levels and bound the enzyme with
almost 2-fold higher affinity than f12-3T (Fig. 2A and Table
I). This indicates that DNA-PKcs interaction with ssDNA lacks stringent
strand polarity preference.
Importance of the Terminal Nucleotide on DNA-PKcs Kinase Activation
by DNA--
We have previously shown that ssDNA ends are important for
efficient DNA-PKcs kinase activation. This finding raises the
possibility that the terminal nucleotides of the DNA end are
specifically recognized by DNA-PKcs. To explore how alterations of the
chemical nature of the terminal nucleotide influenced DNA-PKcs
activation, a set of DNA fragments was synthesized with hydrophilic
spacers added to each 5' and 3' terminus (Fig.
3B).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
The chemical structure of the 3' and 5'
terminus is important for DNA-PKcs kinase activation.
A, DNA-PKcs (2 nM) was mixed with the DNA
fragments defined in B in kinase buffer. The kinase activity
was measured and related to the maximal kinase activity obtained with
the DNA fragment f12-3T (100 = 310 mol of PO4/mol of
DNA-PKcs/min). The data were fitted to the Michaelis-Menten equation to
obtain Km and Vmax values for
each DNA fragment that is listed in Table I. B, DNA
fragments used in this experiment. The extension on f12-sp1T is
composed of a mixed carbon/ether spacer attached to a single dT
nucleotide. Fragment f12-sp2T has the same spacer with two nucleotides
of dT at the terminus. Fragment f12-3T/3'5'NH3 is similar
to f12-3T but has an amino group attached via a carbon spacer and a
phosphate to the 3' and 5' terminus. For each DNA fragment, the overall
structure of the DNA fragment and the chemical structure of the
unpaired single strands of the 5' termini are shown.
|
|
First, both the 3' and the 5' positions in f12-3T were extended with an
amino-containing spacer (f12-3T3'5'NH3), as indicated in
Fig. 3B. This modification lowered kinase activation 3-fold compared with f12-3T but had only a minor effect on binding as measured
by Km (Table I) or EMSA competition assay (data not
shown). This indicated that the chemical structure of the terminal
nucleotide affected DNA-PKcs kinase activation but not DNA binding.
To assess whether exposure of a correct terminal nucleotide was
sufficient for efficient kinase activation, DNA fragments were
constructed with hydrophilic spacers ending with dT (Fig. 3B). The DNA fragment f12-sp1T contained a single dT linked
via a hydrophilic spacer to the double-stranded portion of the DNA fragment. The spacer had an approximate length corresponding to two
bases. This potentially allowed the terminal dT to reach out the same
distance from the double-stranded portion of the DNA fragment as the
terminal dT in f12-3T (Fig. 3). Therefore, if interaction with the
terminal nucleotide were sufficient, f12-sp1T would activate DNA-PKcs.
However, f12-sp1T bound and activated DNA-PKcs poorly. Even at high
concentrations of f12-sp1T, kinase activation was still 5-fold lower
than that observed with f12-3T. We were unable to reach
Vmax or calculate Km even at increased DNA concentrations (data not shown). The addition of two dT
at the end of the hydrophilic spacer (f12-sp2T) improved activation but
still produced a Vmax 2-fold lower than f12-3T (Table I). Although it is possible that the hydrophilic spacer in
f12-sp1T and f12-sp2T simply inhibited kinase activation in a
nonspecific manner, the data indicated that exposure of the correct DNA
terminus was not sufficient for efficient DNA-PKcs activation and that
the nature of the ssDNA backbone is important for kinase activation.
Effect of Phosphate Backbone Alterations on DNA-PKcs Activation by
DNA--
The effect of DNA backbone alterations was further examined
by means of a set of DNA fragments where the ribose or the phosphate of
the terminal nucleotides were altered, as indicated in Fig. 4B. Single-stranded extensions
of ribonucleotides (f12-3rU) or phosphothioester linkages (f12-3T/thio)
activated DNA-PKcs with a Km and
Vmax close to that obtained with f12-3T (Table I). In contrast, a DNA fragment with methylphosphonate linkages, where
the hydroxyl group in the backbone phosphate was changed to a methyl
group (f12-3T/CH3), activated DNA-PKcs poorly.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Activation of DNA-PKcs involves interaction
with the phosphate backbone in DNA. A, DNA-PKcs (2 nM) was incubated with different concentrations of the DNA
fragments defined in B, and the resulting kinase activity
was measured. The kinase activity was related to the maximal kinase
activity obtained with fragment f12-3T (100 = 345 mol of
PO4/mol of DNA-PKcs/min). The data were fitted to the
Michaelis-Menten equation to obtain Km and
Vmax values for each DNA fragment that is listed
in Table I. B, DNA fragments used in this experiment.
Fragment f12-3rU has ribouridine extensions, f12-3T/thio has extensions
with thioester linkages, and f12-3T/CH3 has extensions with
methylphosphonate linkages. For each DNA fragment, the overall
structure of the DNA fragment and the chemical structure of the three
unpaired nucleotides of the 5' terminus are shown.
|
|
The inefficient activation obtained with f12-3T/CH3 could
be due to poor binding to DNA-PKcs. However, the low kinase activity prevented determination of Km. Therefore, binding of f12-3T/CH3 to DNA-PKcs was examined with an EMSA
competition assay. In this assay, radioactively labeled f12-3T was
mixed with different concentrations of unlabeled f12-3T, f12 or
f12-3T/CH3 before addition of DNA-PKcs. The resulting
DNA-PKcs·DNA complexes were analyzed by electrophoresis and
quantified by a phosphorimager (Fig. 5). F12-3T/CH3 competed almost as efficiently as the f12-3T DNA
fragment. In contrast, the f12 DNA fragment essentially failed to
compete under these conditions. Thus, methylphosphonate-modified DNA
ends bound to DNA-PKcs but failed to activate the kinase
effectively.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 5.
DNA-PKcs binds efficiently to
methylphosphonate-modified DNA. Labeled f12-3T (2 nM)
was mixed with the unlabeled competitor DNA indicated in the figure in
EMSA buffer. DNA-PKcs (4 nM) was added and the resulting
protein-DNA complexes resolved on 4% PAGE as described under
"Materials and Methods." The gels were dried and analyzed by
autoradiography (upper panel) and by a phosphorimager to
allow graphic presentation of the protein-DNA complexes (indicated by
PKcs) in each lane (lower panel).
|
|
The fact that f12-3T/CH3 bound but failed to activate
DNA-PKcs inspired the construction of a hybrid DNA fragment between f12-3T and f12-3T/CH3. By annealing the upper strand from
f12-3T with the lower strand from f12-3T/CH3, a DNA
fragment with one strand permissive for DNA-PKcs activation and one
nonpermissive at each end was produced (f12-3T/1/2CH3). The
resulting hybrid DNA fragment bound and activated DNA-PKcs to levels
close to the activation obtained with f12-3T (Fig.
6 and Table I). Thus, DNA-PKcs was
efficiently activated when only one of the strands of the DNA fragment
was permissive for kinase activation.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
A double-stranded DNA fragment with one
strand of methylphosphonate-modified DNA activates DNA-PKcs.
A, DNA-PKcs (2 nM) was incubated with different
concentrations of the DNA fragments shown in B, and the
resulting kinase activity was measured. The kinase activity was related
to the maximal kinase activity obtained with the DNA fragment f12-3T
(100 = 410 mol of PO4/mol of DNA-PKcs/min)
B, DNA fragments used in this experiment. Fragments f12-3T,
f12, and f12-3T/CH3 are defined in Fig. 3. Fragment
f12-3T/1/2CH3 was formed by annealing the upper strand from
f12-3T with the lower strand from f12-3T/CH3, resulting in
a DNA fragment with one normal and one methylphosphonate-modified
strand at each end.
|
|
Double-stranded RNA Fails to Activate DNA-PKcs--
The finding
that f12-3rU activated DNA-PKcs indicated that the ssDNA binding site
in DNA-PKcs recognized ribonucleotides. This opened the possibility
that DNA-PKcs could be activated by double-stranded RNA ends, although
several previous reports have shown that double-stranded RNA fail to
bind and activate DNA-PK (11, 12, 42). To test this possibility
directly, we synthesized a double-stranded RNA fragment (f12RNA-3rU)
with the exact overall structure as f12-3T and tested it in DNA-PKcs
kinase assays (Fig. 7A). The
data showed that DNA-PKcs was not activated at all by the
double-stranded RNA fragment. In addition, f12RNA-3rU failed to compete
in the EMSA competition assay, indicating that DNA-PKcs was unable to
bind to double-stranded RNA (Fig. 7B). To confirm that the
RNA fragment was correctly synthesized and deprotected the top strand
of f12RNA-3rU and f12-3T was incubated with RNase A or DNase I and
analyzed on denaturing PAGE (Fig. 7C). As expected, f12RNA-3rU-1 was degraded by RNase A and resistant to DNase I, showing
that it displayed a correct RNA structure. Thus, although DNA-PKcs was
activated by a hybrid DNA fragment with three ribonucleotides at the
terminus (f12-3rU), double-stranded RNA with the exact same overall
structure failed to bind and activate DNA-PKcs. This indicates that
DNA-PKcs discriminate RNA ends from DNA ends by its interaction with
the double-stranded portion of DNA ends.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 7.
DNA-PKcs interaction with a double-stranded
RNA fragment. A, the double-stranded RNA fragment,
f12RNA-3rU, failed to activate DNA-PKcs. DNA-PKcs (2 nM)
was incubated with different concentrations of the f12RNA-3rU or
f12-3T, and the resulting kinase activity was measured. The kinase
activity was related to the maximal kinase activity obtained with the
DNA fragment f12-3T (100 = 335 mol of PO4/mol of
DNA-PKcs/min). B, labeled f12-3T DNA fragment (2 nM) was mixed with the unlabeled competitor DNA indicated
in the figure in EMSA buffer. DNA-PKcs (4 nM) was added and
the resulting protein-DNA complexes resolved on 4% PAGE as described
under "Materials and Methods." The gels were dried and analyzed by
autoradiography. C, analysis of f12RNA-3rU-1. The upper
strand of f12RNA-3rU (f12RNA-3rU-1) and f12-3T (f12-3T-1) was labeled
with T4 PNK and digested with RNase A or RNase-free DNase I as
indicated in the figure. Reactions were separated on 20% denaturing
PAGE and analyzed by autoradiography.
|
|
DNA Fragments with Only One ssDNA End Activate DNA-PKcs
Inefficiently--
Several studies indicate that SSBs are poor
activators of DNA-PK (11, 37, 41). At the position of a SSB, the DNA
strands become flexible and capable of exposing ssDNA ends by fraying. A SSB could in theory satisfy the need for ssDNA ends for kinase activation (34). In addition, DNA-PK is potentially able to assemble on
SSBs, since Ku, the DNA-targeting subunit of DNA-PK, binds SSBs (23,
43). It is therefore unclear how DNA-PK is able to distinguish SSBs
from DSBs. However, a SSB is not able to simultaneously expose two
ssDNA ends at the correct distance found at a DSB. Therefore, DNA-PK
could differentiate between SSBs and DSBs if it was dependent on
simultaneous interaction with two ssDNA ends.
To explore whether one or two ssDNA ends were required for kinase
activation, a dumbbell DNA fragment exposing only one 5' ssDNA end was
constructed using a branched oligonucleotide (Fig. 8B). After annealing and
ligation, the fully ligated dumbbell DNA fragment was purified using a
combination of native and denaturing gels (Fig. 8C) (34).
The correct configuration of the 5' ssDNA end in D44-ss5' was verified
by the ability of PNK, which labels only 5' ends, but not TdT, which
labels only 3' ends, to label the fully ligated product (Fig.
8C). In addition, the ability of PNK to efficiently label
D44-ss5' indicated that the ssDNA tail was exposed to the solution.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 8.
Construction of D44-ss5' and the lariat DNA
fragment A. Graphical presentation of the construction of
D44-ss5'. The sequence and structure of the branched oligonucleotide
(f12-2branch) is shown. Note that the sequence of the four terminal
nucleotides of the branches are complementary to the four nucleotides
3' of the branch, allowing formation of a hairpin. First, the
hairpin-forming branched oligonucleotide was annealed to a
complementary oligonucleotide as described under "Materials and
Methods." After ligation (I) and purification of the
ligation product, the branched hairpin oligonucleotide was ligated
(II) to a second hairpin oligonucleotide, resulting in
dumbbell DNA fragment with a single-stranded 5' terminus. For details
see "Material and Methods." B, purification of D44-ss5'.
First, the DNA products formed after ligation II were separated on
native PAGE and stained with ethidium bromide. The DNA in the band
corresponding to the ligation products (lane 1) was
recovered and further purified on denaturing PAGE (lane 2)
that resolve the partially ligated (lower band) and fully
ligated (upper band) products. DNA recovered from the band
in lane 1 was labeled with T4 PNK (lane 3) or TdT
(lane 4), separated on denaturing PAGE, and analyzed by
autoradiography. The fully ligated product (upper band)
failed to label with TdT (specific for 3' terminus), but efficiently
labeled with T4 PNK (specific for 5' terminus), as expected.
C, construction of the lariat DNA fragment. The sequence of
the branched linker oligonucleotide (Branch.1) is shown at the
top. First, the branched linker oligonucleotide was ligated
(I) to the 3' end of oligonucleotide L2. The ligation
product was purified on denaturing PAGE and ligated (II) to
the oligonucleotide L3 that contained a partially complementary
sequence to L2. To mask the complementarity during ligation, L3 was
annealed to an oligonucleotide complementary to this region, prior to
ligation as shown. The ligation product was purified on denaturing PAGE
and allowed to self-anneal. D, verification of the structure
of the lariat DNA fragment. The lariat DNA fragment was labeled with
PNK (lane 1) or TdT (lane 2), separated on 20%
denaturing PAGE, and analyzed by ethidium bromide staining (left
panel) and autoradiography (middle panel). The 68-base
lariat DNA fragment migrated at the expected position and was not
labeled with TdT (specific for 3' terminus), showing that it lacks 3'
ssDNA ends. Proper annealing of the 15-bp double-stranded region was
shown by cleavage of the lariat DNA fragment with the restriction
enzyme BstUI and analysis on 20% denaturing PAGE
(right panel: lane 3, undigested lariat;
lane 4, digested lariat). On a 20% nondenaturing PAGE the
68-base lariat DNA fragment migrated slower than a 71-bp DNA fragment
as expected for a looped DNA fragment. In contrast, the unligated
annealing product between L2 and L3 (L2/L3, lane 6) migrated
at a position reflecting the expected size of the DNA fragment (49 bases).
|
|
D44-ss5' activated DNA-PKcs poorly and to similar levels observed with
a dumbbell DNA fragment without the 5' ssDNA end (D32-Lss5) (Fig.
9) (34)). The poor activation was not due
to the presence of contaminating inhibitors, because restriction enzyme
cleavage of D44-ss5' resulted in robust activation of the kinase to the level observed with a blunt-ended DNA fragment (f48). Because of the
polarity of oligonucleotide synthesis, a corresponding DNA fragment
exposing only one 3' end could not be constructed using a branched
phosphoamidite. However, because DNA-PKcs activation lacked DNA strand
polarity preference (Fig. 2), DNA-PK is likely to be inefficiently
activated by a single 3' terminus as well.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 9.
DNA-PKcs kinase activation by DNA fragments
exposing only one ssDNA end. DNA-PKcs (1.0 nM) was
incubated with 60 nM of the DNA fragments shown in the
figure, and the resulting kinase activity was measured. Kinase activity
was related to the maximal kinase activity obtained with the DNA
fragment f32-ss3'/5' (100 = 395 mol of PO4/mol of
DNA-PKcs/min). To rule out the possibility that the preparation of
D44-ss5'contained any inhibitory activity, D44-ss5' was cleaved with
the restriction endonuclease MluI (D44-ss5'/MluI)
and tested for kinase activation. Error bars represent data
from three separate experiments. D44-ss5' is a dumbbell DNA fragment
with loops of three dT at each end and a six-base 5' ssDNA branch
extending from one end. D34-gap10 is a dumbbell DNA fragment with ssDNA
loops of two dT at each end and a gap of ten bases of dT flanked by 12 bp of double-stranded DNA at each side. The ssDNA ends flanking the gap
contain three bases of unpaired dT. H12-ss3'/5' is a half-dumbbell DNA
fragment with a ssDNA loop of two dT at one end and three and ten bases
of unpaired dT at the 5' and 3' termini, respectively. The sequence of
H12-ss3'/5' is identical to one double-stranded portion including the
gap of D34-gap10. Lariat is a looped DNA fragment with a 15-bp
double-stranded portion and a 44-base single stranded loop connecting
its 3' termini, as described in the legend to Fig. 8D. The
5' termini have 3 bases of unpaired dT. L2/L3 is a 15-bp
double-stranded DNA fragment with ssDNA extensions of 17 bases at the
3' ends and three bases at the 5' ends. L2/L3 was formed by annealing
of the oligonucleotides used to construct the lariat DNA fragment.
D32-ssL5 is a 32-bp dumbbell DNA fragment with loops of five dT at each
end. Fragment f42 is a blunt-ended 42-bp DNA fragment and f32-ss3'/5'
is a 32-bp DNA fragment with five bases of unpaired dT at each end. DNA
fragments are further defined in Ref. 34.
|
|
While the previous data suggest that DNA-PKcs kinase cannot be
activated by a single ssDNA end, an alternative interpretation is that
the hairpin loop at the end of D44-ss5' structurally interferes with
activation by the 5' ssDNA end that would otherwise occur. We therefore
explored DNA-PKcs activation by a similar dumbbell DNA fragment with a
central gap of ten bases on the strand opposite two internal 3' and 5'
ssDNA ends (H34-gap10, Fig. 9). This DNA fragment simulates the
structure of a SSB with frayed DNA strands but may allow better access
to the ssDNA ends due to the ten base gap between the open ends (Fig.
9). In addition, since the ssDNA ends flanking the gap have either 3'
or 5' polarity, strand polarity preference for activation could
potentially be explored. Similar to D44-ss5', the gapped DNA fragment
activated DNA-PKcs poorly. A DNA fragment identical to one side of
D34-gap10 (H12-ss3'5') efficiently activated DNA-PKcs, ruling out the
possibility that D34-gap10 failed to activate DNA-PKcs due to the
presence of a long ssDNA region or loop (Fig. 9).
Finally, we constructed a lariat DNA fragment by fusing the 3'-ends of
two complementary oligonucleotides. The 3' ends of the complementary
oligonucleotides were fused by ligation to a branched linker
oligonucleotide containing two phosphorylated 5' ends (Fig.
8C). The resulting oligonucleotide self-annealed to a looped
DNA fragment, with a 15-bp double-stranded region flanked by
exclusively 5' ssDNA ends (Fig. 8, C and D). As
shown in Fig. 9, the lariat DNA fragment failed to activate DNA-PKcs. In contrast, when the same oligonucleotides used for construction of
the lariat were annealed without fusion of the 3'-termini (L2/L3), DNA-PKcs was efficiently activated, ruling out the possibility that
long ssDNA regions in the lariat interfered with kinase activation.
Therefore, the inability of three distinct DNA constructs that expose
only one ssDNA end (D44-ss5', D34-gap10, and the lariat DNA fragment)
to efficiently activate DNA-PKcs suggests that robust activation of
DNA-PKcs involves simultaneous interaction with two ssDNA ends.
 |
DISCUSSION |
In previous reports, we have shown that ssDNA ends activate
DNA-PKcs. This provided a possible explanation for how DNA-PK is
specifically activated by broken DNA, since the DNA backbone must be
damaged to expose the necessary ssDNA ends. The data did not clarify
why SSBs activate DNA-PK poorly nor which part of the ssDNA ends is
recognized by DNA-PK. The molecular details of DNA-PK kinase activation
by DNA ends are important to understand how the cell is able to
recognize the chemically diverse structures that occur when DSBs are
introduced by ionizing radiation.
Collectively, our data indicate that DNA-PKcs has a relaxed specificity
for the chemical structure of the terminal nucleotides of a DNA end.
DNA fragments with abasic nucleotides bound and activated DNA-PKcs to
the same extent as a DNA fragment ending with unpaired dA. This
suggests that the base position in DNA is not specifically contacted by
DNA-PKcs. It is therefore unlikely that the base modifications
introduced by ionizing radiation will impede DNA-PK activation. DNA
fragments with exclusively 3' or 5' polarity at the ends both activated
DNA-PKcs, indicating a lack of strand polarity preference. No effect on
DNA binding and kinase activation was evident when the terminal
nucleotides were replaced by ribonucleotides or nucleotides with
phosphothioester linkages. We also found that to prevent activation of
DNA-PKcs a DSB must contain an incompatible chemical modification on
both strands (Fig. 6). The data indicate that the ssDNA binding site in
DNA-PKcs accepts a wide variety of chemical modifications, lacks strand
polarity preference, and allows activation by DSBs even when one of the
strands is incompatible with activation. Therefore, production of DSBs
that avoid detection by DNA-PK is likely to be a rare event. This is in
line with the finding that linear plasmid DNA generated by
radiation activates DNA-PK to the same extent as plasmid DNA cleaved
with restriction enzymes (37). However, it is possible that more
complex DSBs produced by high linear energy transfer radiation (44) and
drugs such as calicheamicin or etoposide are not recognized by DNA-PK.
In fact, DNA ends damaged with the anticancer drug
cis-platin are unable to activate DNA-PK, and this could
explain the ability of cis-platin to sensitize cells to
ionizing radiation (38-40).
Three findings indicate that, in addition to the requirement for ssDNA
ends, interaction with the DNA backbone is important for kinase
activation. A DNA fragment extended with a hydrophilic spacer holding a
dT at each of the four ssDNA ends bound and activated DNA-PKcs poorly.
Although it is possible that the hydrophilic spacer simply interfered
with activation, the data suggested that exposure of a correct terminal
nucleotide was not sufficient for kinase activation. This indicated
that efficient activation of DNA-PKcs involved interaction with the DNA
backbone. This conclusion was further strengthened by the finding that
methylphosphonate-modified DNA was bound by DNA-PKcs but activated its
kinase poorly. The methylphosphonate modification replaces the
negatively charged hydroxyl group in the phosphate backbone, resulting
in an uncharged backbone. This suggest that the negative charge of the
DNA backbone is required for kinase activation but not for binding. In
addition we found, in agreement with others, that a double-stranded RNA fragment was unable to activate DNA-PKcs (11, 12). However, a hybrid
DNA fragment with identical overall structure but with three ribonucleotides at all four single-stranded ends activated DNA-PKcs efficiently. This indicates that the ssDNA binding site in
DNA-PKcs fails to distinguish RNA from DNA strands. Therefore DNA-PK
must distinguish RNA from DNA by its interactions with the
double-stranded portion of DNA ends. Together these three observations
show that interactions with the backbone, not just the ssDNA ends, of a
DSB is involved in DNA-PKcs kinase activation.
Ionizing radiation produces 10-fold more SSBs in DNA compared with DSBs
(44). SSBs are known to be relatively nontoxic to cells (44) and are
quickly repaired. In contrast, the few DSBs that are produced by
ionizing radiation are very toxic to cells and take several hours to be
fully repaired (45, 46). Thus, cells have a potent signaling system
capable of distinguishing between SSBs and DSBs. Several reports
indicate that DNA-PK is inefficiently activated by SSBs (11, 37, 41).
It is therefore possible that DNA-PK plays a role in the discrimination
among SSBs and DSBs in the cell. This possibility is supported by the finding that DNA-PK-deficient cells repair DSBs inefficiently, but have
no defect in SSB repair (47, 48). One way for DNA-PK to discriminate
between DSBs and SSBs is by simultaneous interaction with two ssDNA
ends. A SSB is unable to expose two ssDNA ends with the configuration
found in the context of a DSB. Therefore, a requirement for two ssDNA
ends would render DNA-PK activation specific for DSBs. In support for
this possibility, we found that three distinct DNA constructs that
expose only one ssDNA end (D44-ss5', D34-gap10, and the lariat DNA
fragment) activated DNA-PKcs poorly. It is possible that these DNA
fragments contain structures that mask activation by a single ssDNA
end. However, the combined data support the possibility that DNA-PK
discriminates SSB from DSB by a requirement for interaction with two
ssDNA ends for efficient kinase activation.
Based on a low resolution structure of DNA-PKcs, we have proposed that
DNA-PKcs is activated when one ssDNA end enters an enclosed channel
present in the enzyme (Fig.
10A). Although this model
potentially explains the requirement for ssDNA ends for activation, it
does not provide a good explanation why DNA-PKcs seemes to require
simultaneous interaction with two single strands for activation (Fig.
9). One possibility is that activation of DNA-PKcs requires
dimerization of two DNA-PKcs molecules each bound to a DNA end as we
suggested previously (34) (Fig. 10B). This configuration
would have the added benefit of restricting full activation of DNA-PK
until synapsis of the two ends of a DSB is complete. Since the
uncharged backbone of methylphosphonate-modified DNA bound DNA-PKcs but
failed to activate its kinase activity, it is possible that specific
contacts with the charged phosphate backbone are involved in kinase
activation. According to this model, interaction with the charged
phosphate could occur within the enclosed channel.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 10.
A model for DNA-PKcs activation by two ssDNA
ends. A, electron crystallography structure of DNA-PKcs
with superimposed cartoon of a bound DNA end (35). According to this
model the double-stranded portion of a DNA end binds to the open
channel in DNA-PKcs. Interaction with ssDNA occurs when the DNA is
melted and inserted into an opening of the enclosed channel present in
DNA-PKcs. The dashed line indicates the location of the
cross-sectional slice through the molecule used to produce the cartoon
shown in B. B, model for how DNA-PKcs is
activated by two ssDNA ends. Using the cross-sectional slice as a
model, two DNA-bound DNA-PKcs molecules first form a synapsis complex.
The kinases are activated in concert when two ssDNA ends are threaded
into two openings of the enclosed channel in each enzyme.
|
|
In conclusion, we have found that DNA-PKcs recognizes DNA ends
containing a wide range of modified nucleotides and seems to require
simultaneous interaction with two ssDNA ends for activation. These
properties potentially make DNA-PK activation specific for DSBs but
still capable of recognizing DNA ends with damaged terminal nucleotides. DNA-PK is therefore a suitable candidate for detection of
DSBs when cells are damaged by ionizing radiation. With this knowledge
it will be interesting to examine DNA-PK recognition of cross-linked
DNA fragments and complex strand breaks such as those produced by
cytotoxic cancer therapy and high linear energy transfer radiation.
 |
ACKNOWLEDGEMENTS |
We thank Lisa G. DeFazio and James Lorens for
advice and careful reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by the Swedish Cancer Society, the
Swedish research council, King Gustav V Jubilee Clinic Cancer Research Foundation, and Sahlgren's Hospital Research Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom corresepondence should be addressed. Fax: 46-31-82-84-58;
E-mail: ola.hammarsten@clinchem.gu.se.
Published, JBC Papers in Press, November 7, 2001, DOI 10.1074/jbc.M106711200
 |
ABBREVIATIONS |
The abbreviations used are:
DSB, double-stranded
break;
EMSA, electromobility shift assay;
TdT, terminal
deoxynucleotidyltransferase;
PNK, T4 polynucleotid kinase;
ssDNA, single-stranded DNA;
SSB, single-stranded break;
dT, deoxythymidine;
dA, deoxyadenine;
DNA-PK, DNA-dependent protein kinase;
DNA-PKcs, DNA end-activated protein kinase composed of a catalytic
subunit;
TEAA, triethylammonium acetate.
 |
REFERENCES |
| 1.
|
Ross, G.
(1999)
Endocr. Relat Cancer
6,
41-44
|
| 2.
|
Banin, S.,
Moyal, L.,
Shieh, S.-Y.,
Taya, Y.,
Anderson, C.,
Chessa, L.,
Smorodinsky, N.,
Prives, C.,
Reiss, Y.,
Shiloh, Y.,
and Ziv, Y.
(1998)
Science
281,
1674-1677
|
| 3.
|
Durocher, D.,
and Jackson, S.
(2001)
Curr. Opin. Gen. Dev.
13,
225-231
|
| 4.
|
Tibbets, R.,
Brumbaugh, K.,
Williams, J.,
Sarkaria, J.,
Cilby, W.,
Shieh, S.-Y.,
Taya, Y.,
Prives, C.,
and Abraham, R.
(1999)
Gene Dev.
13,
152-157
|
| 5.
|
Lakin, N.,
Hann, B.,
and Jackson, S.
(1999)
Oncogene
18,
3989-3995
|
| 6.
|
Hall-Jackson, C.,
Cross, D.,
Morries, N.,
and Smythe, C.
(2000)
Oncogene
18,
6707-6713
|
| 7.
|
Resnick, M. A.
(1976)
J. Theor. Biol.
59,
97-106
|
| 8.
|
Game, J.
(1993)
Semin. Cancer Biol.
4,
73-83
|
| 9.
|
Frankenberg-Schwager, M.
(1989)
Radiother. Oncol.
14,
307-320
|
| 10.
|
Di Leonardo, A.,
Linke, S. P.,
Clarkin, K.,
and Wahl, G. M.
(1994)
Genes Dev.
8,
2540-2551
|
| 11.
|
Carter, T.,
Vancurova, I.,
Sun, I.,
Lou, W.,
and DeLeon, S.
(1990)
Mol. Cell. Biol.
10,
6460-6471
|
| 12.
|
Gottlieb, T. M.,
and Jackson, S. P.
(1993)
Cell
72,
131-142
|
| 13.
|
Rathmell, W. K.,
and Chu, G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7623-7627
|
| 14.
|
Ting, N.,
Chan, D.,
Lintott, L.,
Allalunis-Turner, J.,
and Lees-Miller, S.
(1999)
Radiat. Res.
151,
414-422
|
| 15.
|
Kurimasa, A.,
Kumano, S.,
Boubnov, N.,
Story, M.,
Tung, C. S.,
Peterson, S.,
and Chen, D.
(1999)
Mol. Cell. Biol.
19,
3877-3884
|
| 16.
|
Baumann, P.,
and West, S. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14066-14070
|
| 17.
|
Hendrickson, E.,
Qin, X. Q.,
Bump, E.,
Schatz, D.,
Oettinger, M.,
and Weaver, D.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4061-4065
|
| 18.
|
Fulop, G. M.,
and Phillips, R. A.
(1990)
Nature
347,
479-482
|
| 19.
|
Guan, J.,
DiBiase, S.,
and Iliakis, G.
(2000)
Nucleic Acids Res.
28,
1183-1192
|
| 20.
|
Wang, S.,
Guo, M.,
Ouyang, H., Li, X.,
Cordon-Cardo, C.,
Kurimasa, A.,
Chen, D.,
Fuks, Z.,
Ling, C.,
and Li, G.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1584-1588
|
| 21.
|
Hartley, K. O.,
Gell, D.,
Smith, G. C. M.,
Zhang, H.,
Divecha, N.,
Connelly, M. A.,
Admon, A.,
Lees-Miller, S. P.,
Anderson, C. W.,
and Jackson, S. P.
(1995)
Cell
82,
849-856
|
| 22.
|
Mimori, T.,
and Hardin, J. A.
(1986)
J. Biol. Chem.
261,
10375-10379
|
| 23.
|
Falzon, M.,
Fewell, J. W.,
and Kuff, E. L.
(1993)
J. Biol. Chem.
268,
10546-10552
|
| 24.
|
Paillard, S.,
and Strauss, F.
(1991)
Nucleic Acids Res.
19,
5619-5624
|
| 25.
|
de Vries, E.,
van Driel, W.,
Bergsma, W. G.,
Arnberg, A. C.,
and van der Vliet, P. C.
(1989)
J. Mol. Biol.
208,
65-78
|
| 26.
|
Walker, J.,
Corpina, R.,
and Goldbreg, J.
(2001)
Nature
412,
607-614
|
| 27.
|
Yaneva, M.,
Kowalewski, T.,
and Lieber, M.
(1997)
EMBO J.
16,
5098-5112
|
| 28.
|
Hammarsten, O.,
and Chu, G.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
525-530
|
| 29.
|
West, R.,
Yaneva, M.,
and Lieber, M.
(1998)
Mol. Cell. Biol.
18,
5908-5920
|
| 30.
|
Suwa, A.,
Hirakata, M.,
Takeda, Y.,
Jesch, S.,
Mimori, S.,
and Hardin, J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6904-6908
|
| 31.
|
Gell, D.,
and Jackson, S.
(1999)
Nucleic Acids Res.
27,
3494-3502
|
| 32.
|
Singleton, B.,
Torres-Arzayus, M.,
Rottinghaus, S.,
Taccioli, G.,
and Jeggo, P.
(1999)
Mol. Cell. Biol.
19,
3267-3277
|
| 33.
|
Yoo, S.,
and Dynan, W.
(1999)
Nucleic Acids Res.
27,
4679-4686
|
| 34.
|
Hammarsten, O.,
DeFazio, L.,
and Chu, G.
(2000)
J. Biol. Chem.
275,
1541-1550
|
| 35.
|
Leuther, K. K.,
Hammarsten, O.,
Kornberg, R. D.,
and Chu, G.
(1999)
EMBO J.
18,
1114-1123
|
| 36.
|
Friedberg, E. C.,
Walker, G. C.,
and Siede, W.
(1995)
DNA Repair and Mutagenesis
, pp. 20-24, ASM Press, Washington, D. C.
|
| 37.
|
Weinfeld, M.,
Chaudhry, M.,
D'Amours, D.,
Pelletier, J.,
Poirer, G.,
Povirk, L.,
and Lees-Miller, S.
(1998)
Radiat. Res.
148,
22-28
|
| 38.
|
Turchi, J. J.,
and Henkels, K.
(1996)
J. Biol. Chem.
271,
13861-13867
|
| 39.
|
Turchi, J. J.,
Patrick, S. M.,
and Henkels, K. M.
(1997)
Biochemistry
36,
7586-7593
|
| 40.
|
Turchi, J.,
Henkels, M.,
and Zhou, Y.
(2000)
Nucleic Acids Res.
28,
4634-4641
|
| 41.
|
Smider, V.,
Rathmell, W. K.,
Brown, G.,
Lewis, S.,
and Chu, G.
(1998)
Mol. Cell. Biol.
18,
6853-6858
|
| 42.
|
Yoo, S.,
and Dynan, W.
(1998)
Biochemistry
37,
1336-1343
|
| 43.
|
Blier, P.,
Griffith, A.,
Craft, J.,
and Hardin, J.
(1993)
J. Biol. Chem.
268,
7594-7601
|
| 44.
|
Nias, A.
(1998)
An Introduction to Radiobiology
, 2nd Ed.
, pp. 102-105, John Wiley & Sons, New York
|
| 45.
|
Wang, H.,
Zeng, Z.,
Bui, T.,
DiBiase, S.,
Qin, W.,
Xia, F.,
Powell, S.,
and Iliakis, G.
(2001)
Cancer Res.
61,
270-277
|
| 46.
|
Wang, H.,
Zeng, Z.,
Bui, T.,
Sonoda, E.,
Takata, M.,
Takeda, S.,
and Iliakis, G.
(2001)
Oncogene
20,
2212-2224
|
| 47.
|
Kemp, L.,
Sedgwick, S.,
and Jeggo, P.
(1984)
Mutat. Res
132,
189-196
|
| 48.
|
Darroudi, F.,
Natarajan, A.,
van der Schans, G.,
and van Loon, A.
(1990)
Mutat. Res.
235,
119-127
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. C. Shank, J. B. Kelley, D. Gioeli, C.-S. Yang, A. Spencer, L. A. Allison, and B. M. Paschal
Activation of the DNA-dependent Protein Kinase Stimulates Nuclear Export of the Androgen Receptor in Vitro
J. Biol. Chem.,
April 18, 2008;
283(16):
10568 - 10580.
[Abstract]
[Full Text]
[PDF]
|